About Houman Hemmati
Houman Hemmati is a board member at Noveome Biotherapeutics.
Form D filings also name Houman Hemmati as a director at Trailhead Biosystems.
Houman Hemmati first appears on SEC filings in 2020.
Experience
This experience comes from Houman Hemmati's profile and from SEC filings. For roles taken from filings, the years are when the filings name Houman Hemmati in the role, so the role may have started earlier or lasted longer.
LB
Lento Bio Current
Member Board of Directors
2024 – Present
Noveome Biotherapeutics, Inc. Current
Board Member
Member Board of Directors (2022 – Present)
2022 – Present · Pittsburgh, PA
Develops experimental biologic treatments for infants with a serious intestinal disease and other patients.
VY
Vyluma Current
Chief Medical Affairs Officer
2021 – Present
Trailhead Biosystems Inc. Current
Member Board Of Directors
2020 – Present · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
OB
Optigo Biotherapeutics Current
Co-Founder, Chief Medical Officer
2018 – Present
LL
Levation Pharma, Ltd. Current
Co-Founder, Chief Scientific Officer
2017 – Present
NI
Novateur Ventures Inc. Current
Senior Ophthalmology Investment & Development Advisor
2017 – Present
KU
Keck Medicine of USC Current
Adjunct Clinical Assistant Professor, Ophthalmology
2014 – Present
MO
MediPrint Ophthalmics
Member Board Of Directors
2020 – 2025
CI
Capricor Therapeutics, Inc.
Vice President of Medical and Clinical Development for New Therapies
2015 – 2017
AL
Allergan
Director, Clinical Development
2013 – 2015
HS
Harvard Medical School
Cornea & Refractive Surgery Fellow - Massachusetts Eye & Ear - HMS Department of Ophthalmology
2010 – 2012
MM
Massachusetts Institute of Technology (MIT)
Postdoctoral Scholar
2010 – 2012
JH
Johns Hopkins Hospital
Ophthalmology Resident - Wilmer Eye Institute
2007 – 2010
SC
Stanford University Medical Center
Internal Medicine Intern
2006 – 2007
GL
GriffenRose, LLC
Medical Expert
2005 – 2007
Key Colleagues at Startups
The people Houman Hemmati works with at each company, as listed on that company's latest Form D.
Noveome Biotherapeutics, Inc. · Form D, Aug 27, 2026
Michael Kaufman
Director
EK
Eric Keller
Board Member/President
Ronald Poropatich
Board Member/Chairman of the Board
RL
Robert Langer
Director
Patrick Welch
CEO/Board Member
Larry Brown
Executive officer
Karin Potoka
Chief Medical Officer
Craig Nemiroff
Board Member
Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
Wolfgang Hofmann
Board Member, Trailhead Biosystems
Craig Nemiroff
Managing Director, MAK Capital
David Llewellyn
President and Chief Executive Officer, director
Joshua Snow
Chief Commercial Officer
Jan Jensen
Board Member, Trailhead Biosystems
Divya Trivedi
Chief Operating Officer
Michael Kaufman
Chief Executive Officer, MAK Capital and director